JPRN-UMIN000027629已完成2 期
A single arm confirmatory study of pembrolizumab in patients with previously untreated advanced sarcomatoid carcinoma of the lung - A confirmatory study of pembrolizumab in patients with advanced sarcomatoid carcinoma of the lung
Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital0 个研究点目标入组 22 人开始时间: 2017年6月12日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 22
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1. Active auto-immune disease 2. Interstitial lung disease or pulmonary fibrosis 3. Active infection such as bacteria, HBV, or HCV
研究者
相似试验
招募中
2 期
Clinical trial of combined therapy with pembrolizumab and lenvatinib for patients with classic Kaposi sarcoma treated with at least one previous line of chemioterapy.2024-512834-14-00Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico25
进行中（未招募）
1 期
Study on Pembrolizumab in preneoplastic high grade HPV-related vulvar and cervical lesionsPatients with pre neoplastic high grade HPV-related vulvar and cervical lesionsMedDRA version: 20.0Level: PTClassification code 10054932Term: Vulvar dysplasiaSystem Organ Class: 10038604 - Reproductive system and breast disordersMedDRA version: 20.0Level: PTClassification code 10008263Term: Cervical dysplasiaSystem Organ Class: 10038604 - Reproductive system and breast disordersEUCTR2019-002247-23-ITFONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS UNIVERSITA' CATTOLICA DEL SACRO CUORE46
进行中（未招募）
1 期
A Phase II Study of Pembrolizumab in Subjects with Gastric CancerGastric CancerEUCTR2014-003574-16-FRMerck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.270
进行中（未招募）
1 期
A Phase II Study of Pembrolizumab in Subjects with Gastric CancerGastric CancerEUCTR2014-003574-16-LTMerck Sharp & Dohme Corp., a Subsidiary of Merck & Co., Inc.253
进行中（未招募）
1 期
A Phase II Study of Pembrolizumab in Subjects with Gastric CancerMedDRA version: 20.0Level: PTClassification code 10001150Term: Adenocarcinoma gastricSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Gastric cancerEUCTR2014-003574-16-ITMERCK SHARP & DOHME CORP. UNA SUSSIDIARIA DI MERCK & CO. INC.315